EMEA (Europe, Middle East and Africa) Blood Glucose Device Market Report 2019

REPORT ID 6543

EMEA (Europe, Middle East and Africa) Blood Glucose Device Market Report 2019

Publish Date

2019

Pages

106

Format

Electronic (PDF)

Full report description

In this report, the EMEA Blood Glucose Device market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Blood Glucose Device for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Blood Glucose Device market competition by top manufacturers/players, with Blood Glucose Device sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories (U.S.)
    ARKRAY (Japan)
    Dexcom (U.S.)
    F.Hoffmann-La Roche Ltd (Switzerland)
    Johnson & Johnson (U.S.)
    Medtronic (U.S.)
    Nipro Diagnostics (U.S.)
    Terumo Medical Corporation (U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Product
        Blood Glucose Monitors
        Glucose Monitoring Strips
        Lancets
    By Type
        Single Point Blood Glucose Meters
        Continuous Glucose Monitoring Systems

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Diagnostics
    Home Settings
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of contents

Table of Contents

EMEA (Europe, Middle East and Africa) Blood Glucose Device Market  Report 2019
1 Blood Glucose Device Overview
    1.1 Product Overview and Scope of Blood Glucose Device
    1.2 Classification of Blood Glucose Device
        1.2.1 EMEA Blood Glucose Device Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Blood Glucose Device Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Blood Glucose Monitors
        1.2.4 Glucose Monitoring Strips
        1.2.5 Lancets
    1.3 EMEA Blood Glucose Device Market by Application/End Users
        1.3.1 EMEA Blood Glucose Device Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospitals
        1.3.3 Diagnostics
        1.3.4 Home Settings
        1.3.5 Others
    1.4 EMEA Blood Glucose Device Market by Region
        1.4.1 EMEA Blood Glucose Device Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Blood Glucose Device ( 2014-2024)
        1.5.1 EMEA Blood Glucose Device Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Blood Glucose Device Revenue and Growth Rate ( 2014-2024)

2 EMEA Blood Glucose Device Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Blood Glucose Device Market Competition by Players/Manufacturers
        2.1.1 EMEA Blood Glucose Device Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Blood Glucose Device Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Blood Glucose Device Sale Price by Players ( 2014-2019)
    2.2 EMEA Blood Glucose Device (Volume and Value) by Type/Product Category
        2.2.1 EMEA Blood Glucose Device Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Blood Glucose Device Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Blood Glucose Device Sale Price by Type ( 2014-2019)
    2.3 EMEA Blood Glucose Device (Volume) by Application
    2.4 EMEA Blood Glucose Device (Volume and Value) by Region
        2.4.1 EMEA Blood Glucose Device Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Blood Glucose Device Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Blood Glucose Device Sales Price by Region ( 2014-2019)

3 Europe Blood Glucose Device (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Blood Glucose Device Sales and Value ( 2014-2019)
        3.1.1 Europe Blood Glucose Device Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Blood Glucose Device Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Blood Glucose Device Sales and Market Share by Type
    3.3 Europe Blood Glucose Device Sales and Market Share by Application
    3.4 Europe Blood Glucose Device Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Blood Glucose Device Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Blood Glucose Device Revenue by Countries ( 2014-2019)
        3.4.3 Germany Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        3.4.4 France Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Blood Glucose Device Sales and Growth Rate ( 2014-2019)

4 Middle East Blood Glucose Device (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Blood Glucose Device Sales and Value ( 2014-2019)
        4.1.1 Middle East Blood Glucose Device Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Blood Glucose Device Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Blood Glucose Device Sales and Market Share by Type
    4.3 Middle East Blood Glucose Device Sales and Market Share by Application
    4.4 Middle East Blood Glucose Device Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Blood Glucose Device Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Blood Glucose Device Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Blood Glucose Device Sales and Growth Rate ( 2014-2019)

5 Africa Blood Glucose Device (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Blood Glucose Device Sales and Value ( 2014-2019)
        5.1.1 Africa Blood Glucose Device Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Blood Glucose Device Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Blood Glucose Device Sales and Market Share by Type
    5.3 Africa Blood Glucose Device Sales and Market Share by Application
    5.4 Africa Blood Glucose Device Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Blood Glucose Device Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Blood Glucose Device Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Blood Glucose Device Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Blood Glucose Device Sales and Growth Rate ( 2014-2019)

6 EMEA Blood Glucose Device Manufacturers/Players Profiles and Sales Data
    6.1 Abbott Laboratories (U.S.)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Blood Glucose Device Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 ARKRAY (Japan)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Blood Glucose Device Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Dexcom (U.S.)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Blood Glucose Device Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 F.Hoffmann-La Roche Ltd (Switzerland)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Blood Glucose Device Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Johnson & Johnson (U.S.)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Blood Glucose Device Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Medtronic (U.S.)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Blood Glucose Device Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Nipro Diagnostics (U.S.)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Blood Glucose Device Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Terumo Medical Corporation (U.S.)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Blood Glucose Device Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview

7 Blood Glucose Device Manufacturing Cost Analysis
    7.1 Blood Glucose Device Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Blood Glucose Device

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Blood Glucose Device Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Blood Glucose Device Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Blood Glucose Device Market Forecast ( 2019-2025)
    11.1 EMEA Blood Glucose Device Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Blood Glucose Device Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Blood Glucose Device Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Blood Glucose Device Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Blood Glucose Device Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Blood Glucose Device Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Blood Glucose Device Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer